Vivos Inc. Insider Trading

RDGL

⊜ Compare

Last 12 months

Insiders bought 166K on the open market and sold nothing.

Net open-market

+166K

11 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Sep 2026

Sep 30, 2026

Get an email when RDGL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 30	Michael K Korenko CEO	Bought	200,000	$0.50	100K	1.7%	Form 4
Sep 16	Brad Allan Weeks President	Bought	25,550	$0.05	1K	1.7%	Form 4
Aug 10	Brad Allan Weeks President	Bought	50,000	$0.05	3K	3.4%	Form 4
Aug 10	Michael K Korenko CEO and President	Bought	150,000	$0.05	8K	1.3%	Form 4
Jul 21 – 22	Brad Allan Weeks President	Bought 2 parts	92,000	$0.05 average	5K	6.7%	Form 4
Jul 15	Michael K Korenko CEO and President	Bought	200,000	$0.06	12K	1.8%	Form 4
Jul 9 – 10	Brad Allan Weeks President	Bought 2 parts	60,000	$0.08 average	5K	4.5%	Form 4
May 11	Michael K Korenko CEO and President	Bought	150,000	$0.06	9K	1.4%	Form 4
Dec 31, 2025	Michael K Korenko CEO and President	Bought	200,000	$0.06	12K	1.9%	Form 4
Dec 2, 2025	Michael K Korenko CEO and President	Bought	100,000	$0.07	7K	0.9%	Form 4
Nov 20, 2025	Michael K Korenko CEO and President	Bought	100,000	$0.06	6K	0.9%	Form 4
Aug 14, 2025	Michael K Korenko CEO and President	Bought	100,000	$0.08	8K	1.0%	Form 4

Sep 30
Michael K Korenko
CEO · bought 200,000 at $0.50
100K
1.7% of stake
Sep 16
Brad Allan Weeks
President · bought 25,550 at $0.05
1K
1.7% of stake
Aug 10
Brad Allan Weeks
President · bought 50,000 at $0.05
3K
3.4% of stake
Aug 10
Michael K Korenko
CEO and President · bought 150,000 at $0.05
8K
1.3% of stake
Jul 21 – 22
Brad Allan Weeks
President · bought 92,000 at avg $0.05
5K
6.7% of stake
Jul 15
Michael K Korenko
CEO and President · bought 200,000 at $0.06
12K
1.8% of stake
Jul 9 – 10
Brad Allan Weeks
President · bought 60,000 at avg $0.08
5K
4.5% of stake
May 11
Michael K Korenko
CEO and President · bought 150,000 at $0.06
9K
1.4% of stake
Dec 31, 2025
Michael K Korenko
CEO and President · bought 200,000 at $0.06
12K
1.9% of stake
Dec 2, 2025
Michael K Korenko
CEO and President · bought 100,000 at $0.07
7K
0.9% of stake
Nov 20, 2025
Michael K Korenko
CEO and President · bought 100,000 at $0.06
6K
0.9% of stake
Aug 14, 2025
Michael K Korenko
CEO and President · bought 100,000 at $0.08
8K
1.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RDGL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with RDGL

CompareIntrinsic value

PAVMPAVmed Inc.

$1.66-8.79%25

MBOTMicrobot Medical Inc.

$1.14+4.59%25

SIGYSigyn Therapeutics Inc.

$0.03+0.00%30

NVNOEnVVeno Medical Corporation

$7.00-2.43%10

FOFAFamily Office of America Inc.

$0.78+0.00%16

LYRALyra Therapeutics Inc.

$0.19+0.00%0

CODXCo-Diagnostics Inc.

$0.36-5.00%10

EMEDElectromedical Technologies Inc.

$0.00+0.00%26

Spot a number that looks wrong? Check it in RDGL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RDGL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.